Evidence map›Paper›PMID 26627718›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Designer and natural peptide toxin blockers of the KcsA potassium channel identified by phage display.

Ruiming Zhao, Hui Dai, Netanel Mendelman, Luis G Cuello, Jordan H Chill, Steve A N Goldstein

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Molecular determinants of inhibition of the human proton channel hHv1 by the designer peptide C6 and a bivalent derivative.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  5. The Kv1.3 KBiologia futura · 2021
    Review
  6. Peptide Toxins Targeting KV Channels.Handbook of experimental pharmacology · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Ruiming ZhaoDepartment of Biochemistry, Brandeis University, Waltham, MA 02453;
Hui DaiDepartment of Biochemistry, Brandeis University, Waltham, MA 02453;
Netanel MendelmanDepartment of Chemistry, Bar Ilan University, Ramat Gan 52900, Israel;
Luis G CuelloDepartment of Cell Physiology and Molecular Biophysics, Center for Membrane Protein Research, Texas Tech University Health Center, Lubbock, TX 79430.
Jordan H ChillDepartment of Chemistry, Bar Ilan University, Ramat Gan 52900, Israel;
Steve A N GoldsteinDepartment of Biochemistry, Brandeis University, Waltham, MA 02453; goldstein@brandeis.edu.
Brandeis University · USBar-Ilan University · ILTexas Tech University Health Sciences Center · US

Funding

High-resolution crystallographic and functional studies of K+ channel gatingR01GM097159 · NIGMS · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI CUELLO, LUIS GONZALO · 2012 to 2021
$2.7M
Channels with KCNE Subunits: Conformational DynamicsR01HL105949 · NHLBI · BRANDEIS UNIVERSITY · PI GOLDSTEIN, STEVE A N · 2011 to 2015
$1.5M
De novo protein neurotoxins for ion channelsR01GM111716 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI GOLDSTEIN, STEVE A N · 2015 to 2018
$1.2M
NHLBI NIH HHS R01 HL105949NHLBI NIH HHS R01HL105959NIGMS NIH HHS R01 GM097159NIGMS NIH HHS R01 GM111716
6 · The paper itself

Abstract

Peptide neurotoxins are powerful tools for research, diagnosis, and treatment of disease. Limiting broader use, most receptors lack an identified toxin that binds with high affinity and specificity. This paper describes isolation of toxins for one such orphan target, KcsA, a potassium channel that has been fundamental to delineating the structural basis for ion channel function. A phage-display strategy is presented whereby ∼1.5 million novel and natural peptides are fabricated on the scaffold present in ShK, a sea anemone type I (SAK1) toxin stabilized by three disulfide bonds. We describe two toxins selected by sorting on purified KcsA, one novel (Hui1, 34 residues) and one natural (HmK, 35 residues). Hui1 is potent, blocking single KcsA channels in planar lipid bilayers half-maximally (Ki) at 1 nM. Hui1 is also specific, inhibiting KcsA-Shaker channels in Xenopus oocytes with a Ki of 0.5 nM whereas Shaker, Kv1.2, and Kv1.3 channels are blocked over 200-fold less well. HmK is potent but promiscuous, blocking KcsA-Shaker, Shaker, Kv1.2, and Kv1.3 channels with Ki of 1-4 nM. As anticipated, one Hui1 blocks the KcsA pore and two conserved toxin residues, Lys21 and Tyr22, are essential for high-affinity binding. Unexpectedly, potassium ions traversing the channel from the inside confer voltage sensitivity to the Hui1 off-rate via Arg23, indicating that Lys21 is not in the pore. The 3D structure of Hui1 reveals a SAK1 fold, rationalizes KcsA inhibition, and validates the scaffold-based approach for isolation of high-affinity toxins for orphan receptors.

Indexed as

Amino Acid SequenceAnimalsBacteriophagesMolecular Sequence DataNeurotoxinsPeptidesPotassium Channel BlockersSequence Homology, Amino AcidNeurotoxinsPeptidesPotassium Channel BlockersHmK toxinHui1 toxinNMRsea anemoneShK toxin

Identifiers

PMID26627718
PMCPMC4687576
OpenAlexW2184877100

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.